Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-4vdpqrtPhase 4Completed
Phase 4, randomised, triple-blind trial (2 arms), sponsored by Hospital São Carlos. Primary endpoints: Electroencephalographic changes after dextroketamine versus saline and Between-group and within-group EEG comparisons. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-4vdpqrt.